Newtyn Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PAR Technology
PAR
|
+$54.2M |
| 2 |
USAR
USA Rare Earth Inc
USAR
|
+$45.4M |
| 3 |
Teleflex
TFX
|
+$44.1M |
| 4 |
Weave Communications
WEAV
|
+$40.8M |
| 5 |
QuidelOrtho
QDEL
|
+$37.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Integer Holdings
ITGR
|
+$43.1M |
| 2 |
PPLI
People Inc
PPLI
|
+$20.5M |
| 3 |
CIO
City Office REIT
CIO
|
+$19.6M |
| 4 |
Indivior Pharmaceuticals
INDV
|
+$17.7M |
| 5 |
MRP
Millrose Properties Inc
MRP
|
+$8.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.73% |
| 2 | Industrials | 18.39% |
| 3 | Technology | 11.21% |
| 4 | Communication Services | 11.19% |
| 5 | Real Estate | 5.89% |
No holdings matched the selected filter criteria.
Similar funds
Newtyn Management's Q1 2026 Portfolio in Review
As of Q1 2026, Newtyn Management held 41 positions worth $936M, down 1.7% from $952M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Newtyn Management deployed $188M of net new capital in Q1 2026, opening 9 new positions and adding to 11 existing holdings. Its largest new stake was USA Rare Earth Inc: 2,339,613 shares worth $35.4M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 36% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Indivior Pharmaceuticals, an estimated $17.7M trimmed.
- Newtyn Management's largest Q1 2026 buy was USA Rare Earth Inc: 2,339,613 shares worth $35.4M.
- Newtyn Management added most to PAR Technology in Q1 2026, an estimated $54.2M increase.
- Newtyn Management's biggest Q1 2026 reduction was Indivior Pharmaceuticals, cutting an estimated $17.7M.
- Newtyn Management fully exited Integer Holdings in Q1 2026, selling an estimated $43.1M.
- Newtyn Management's ten largest holdings make up 68% of its $936M portfolio in Q1 2026.
- Newtyn Management opened 9 new positions and closed 8 in Q1 2026.
- Newtyn Management's portfolio value fell 1.7% quarter-over-quarter to $936M.
Based on Newtyn Management's 13F filing for Q1 2026, filed 15 May 2026.